Reply to "decrease in penicillin sales in Brazil after over-the-counter restrictions".
WHO Collaborating Centre for Pharmaceutical Policy & Regulation, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, the Netherlands.
Yared
Y
Santa-Ana-Tellez
WHO Collaborating Centre for Pharmaceutical Policy & Regulation, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, the Netherlands.
Aukje K
AK
Mantel-Teeuwisse
WHO Collaborating Centre for Pharmaceutical Policy & Regulation, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, the Netherlands.
Hubert G M
HG
Leufkens
Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA Center for Health Systems Research, National Institute of Public Health, Cuernavaca, Mexico vwirtz@bu.edu.
Veronika J
http://orcid.org/0000-0002-0863-8768
VJ
Wirtz
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D003132:Commerce / Q000331:legislation & jurisprudence* / Q000706:statistics & numerical data*; D006801:Humans; D004366:Nonprescription Drugs / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D004366:Nonprescription Drugs; D010406:Penicillins